Phase I/II trial of autophagy inhibition in combination with neoadjuvant gemcitabine in patients with high-risk pancreatic adenocarcinoma: Safety, clinical response, and correlative studies.
Michael T. Lotze
No relevant relationships to disclose
Brian A. Boone
No relevant relationships to disclose
Amer H. Zureikat
No relevant relationships to disclose
Nathan Bahary
No relevant relationships to disclose
David Lehman
No relevant relationships to disclose
Lance A. Liotta
No relevant relationships to disclose
Herbert J. Zeh
No relevant relationships to disclose